OPUS 4 | Search

6 search hits

1 to 6

Sort by

Characterization of factors determining the kinetics of disease relapse after allogeneic stem cell transplantation (allo-SCT) or chemotherapeutic consolidation for acute myeloid leukaemia (AML) in first CR: a survey from HOVON-SAKK and the Acute Leukaemia Working Party of the EBMT (2016)

Inferior outcome of allogeneic stem cell transplantation in first complete remission for secondary AML as compared to de novo disease: results from a retrospective, registry-based analysis on behalf of the acute leukemia working party of the EBMT (2018)

Schmid, Christoph ; Labopin, Myriam ; Socie, Gerard ; Itälä-Remes, Maija ; Blaise, Didier ; Yakoub-Agha, Ibrahim ; Milpied, Noel ; Cornelissen, Jan J. ; Ganser, Arnold ; Beelen, Dietrich W. ; Labussière-Wallet, Hélène ; Passweg, Jakob R. ; Savani, Bipin N. ; Mohty, Mohamad ; Nagler, Arnon

Contrasting factors determine the kinetics of disease relapse after allogeneic stem cell transplantation (allo-SCT) for acute myeloid leukaemia (AML): a survey from the Acute Leukaemia Working Party of the EBMT (2014)

Craddock, Charles ; Labopin, Myriam ; Socie, Gerard ; Huyn, Anne ; Deconinck, Eric ; Volin, Liisa ; Milpied, Noel ; Bourhis, Jean-Henri ; Rambaldi, Alessandro ; Chevallier, Patrice ; Cornelissen, Jan J. ; Blaise, Didier ; Maertens, Johann ; Schmid, Christoph ; Nagler, Arnon ; Mohty, Mohamad

Impact of CD3+ and CD34+ doses in the mobilized peripheral blood stem cell grafts on the outcome of reduced-intensity conditioning allogenic transplantation from matched unrelated donors for acute myeloid leukemia: an analysis from the Acute Leukemia Working Party of the EBMT (2014)

Czerw, Tomasz ; Labopin, Myriam ; Schmid, Christoph ; Cornelissen, Jan J. ; Chevallier, Patrice ; Blaise, Didier ; Kuball, Jurgen H. ; Milpied, Noel ; Cahn, Jean-Yves ; Lioure, Bruno ; Fegueux, Nathalie ; Clement, Laurence ; Sandstedt, Anna ; Maertens, Johan ; Guillerm, Gaelle ; Bordessoule, Dominique ; Mohty, Mohamad ; Nagler, Arnon

Allogeneic Hematopoietic Cell Transplantation (alloHCT) for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 (MLL/AF4) B-Acute Lymphoblastic Leukemia in first complete remission (CR1): favorable outcome of patients with negative Minimal Residual Disease (MRD) status at transplant. A report from the Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation (ALWP-EBMT) (2017)

1 to 6